Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Arena

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|May 13, 2008
Understanding how kinase-targeted therapies workSabrina Arena, Alberto Bardelli
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2021
Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challengesErika Durinikova, Kristi Buzo, Sabrina Arena
FEBS Letters|March 15, 2005
Identification of cancer genes by mutational profiling of tumor genomesSilvia Benvenuti, Sabrina Arena, Alberto Bardelli
Journal of Experimental & Clinical Cancer Research : CR|May 15, 2024
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patientsGiada De Lazzari, Alena Opattova, Sabrina Arena
The American Journal of Pathology|June 23, 2009
Expression and functional regulation of myoglobin in epithelial cancersSimona Emilia Flonta, Sabrina Arena, Alberto Pisacane, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2007
Genetic targeting of the kinase activity of the Met receptor in cancer cellsSabrina Arena, Alberto Pisacane, Massimiliano Mazzone, et al.
Cancer Research|August 3, 2007
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cellsFederica Saletta, Giuseppe Matullo, Maurizio Manuguerra, et al.
Human Mutation|November 28, 2013
Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levelsEmily Hannah Crowley, Sabrina Arena, Simona Lamba, et al.
Cancer Research|September 19, 2007
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancersSabrina Arena, Claudio Isella, Miriam Martini, et al.
Oncotarget|August 14, 2014
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligaseMartina Olivero, Daniela Dettori, Sabrina Arena, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|May 13, 2008
Understanding how kinase-targeted therapies workSabrina Arena, Alberto Bardelli
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2021
Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challengesErika Durinikova, Kristi Buzo, Sabrina Arena
FEBS Letters|March 15, 2005
Identification of cancer genes by mutational profiling of tumor genomesSilvia Benvenuti, Sabrina Arena, Alberto Bardelli
Journal of Experimental & Clinical Cancer Research : CR|May 15, 2024
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patientsGiada De Lazzari, Alena Opattova, Sabrina Arena
The American Journal of Pathology|June 23, 2009
Expression and functional regulation of myoglobin in epithelial cancersSimona Emilia Flonta, Sabrina Arena, Alberto Pisacane, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2007
Genetic targeting of the kinase activity of the Met receptor in cancer cellsSabrina Arena, Alberto Pisacane, Massimiliano Mazzone, et al.
Cancer Research|August 3, 2007
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cellsFederica Saletta, Giuseppe Matullo, Maurizio Manuguerra, et al.
Human Mutation|November 28, 2013
Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levelsEmily Hannah Crowley, Sabrina Arena, Simona Lamba, et al.
Cancer Research|September 19, 2007
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancersSabrina Arena, Claudio Isella, Miriam Martini, et al.
Oncotarget|August 14, 2014
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligaseMartina Olivero, Daniela Dettori, Sabrina Arena, et al.
Pageof 6